³¹P-MRS

31-Phosphor-Magnetresonanz-Spektroskopie

ALAT

Alanin-Aminotransferase

AP

Alkalische Phosphatase

ARDS

Acute Respiratory Distress Syndrome

ASAT

Aspartat-Aminotransferase

CI

Konfidenzintervall

CK

Creatinkinase

CR

Komplette Remission (complete response)

CT

Computertomographie

DTIC

Dacarbazin

ELISA

Enzyme linked immuno sorbent assay

EORTC

European Organisation for the Research and Treatment of Cancer

ESHO

European Society for Hyperthermic Oncology

GM-CSF

Granulocyte/macrophage-Colony Stimulating Factor

G-GT

Gamma-Glutamyltransferasse

Gy

Gray

HF

Herzfrequenz

HZV

Herzzeitvolumen

ICAM

Intercellular Adhesion Molecule

IFN

Interferon

IL-6

Interleukin-6

IL-8

Interleukin-8

LDH

Lactatdehydrogenase

MAP

Arterieller Mitteldruck

MFH

Malignes Fibröses Histiozytom

MRT

Magnetresonanztomographie

MTD

Maximal tolerierte Dosis

NC

Unveränderter Befund (no change)

PCR

Phsphocreatin

PCT

Procalcitonin

PD

Progredienter Befund (progressive disease)

PDE

Phosphodiester

PET

Positronenemissions-Tomographie

Pi

Anorganisches Phosphat

PME

Phosphomonoester

PNET

Primitiver Neuroektodermaler Tumor

PR

Partielle Remission

PRIND

Prolonged Reversible Ischiemic Neurlogical Deficiency

RECIST

Response Evaluation Criteria in Solid Tumors

RHT

Regionale Hyperthermie

SIRS

Systemic Inflammatory Response Syndrome

SVR

Peripherer Gefässwiderstand (Systemic Vascular Resistance)

TIA

Transitorische Ischiämische Attacke

TNF

Tumornekrosefaktor

TNF-R

Tumornekrosefaktor-Rezeptor

WHO

World Health Organisation